LOS ANGELES (April 21, 2025)—Perkins Coie is pleased to have advised RadNet, Inc., a leading provider of advanced imaging technologies in healthcare, in its entry into a definitive merger agreement for the acquisition of iCAD, Inc., a medical technology company focused on AI-Powered early detection and diagnosis of breast cancer. The transaction is expected to close in the second or third quarter of 2025. For more information, please see RadNet’s press release here.
The Perkins Coie team was led by partners Andrew Moore, David Martinez, Lisa McGimpsey and Jonathan Schulman, and included counsels Numaan Deen and Chris Wassman, and associate Tina Acevedo.
